UNSPSC 51273806: Antipyrine/benzocaine/glycerin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT400. This VA Drug Class (OT400) classifies this compound as belonging to the group ANALGESICS, TOPICAL OTIC.

UNSPSC 51273806 Antipyrine/benzocaine/glycerin is a Commodity code that in recent state and local procurement activity encompasses a much broader range of pharmaceuticals and over-the-counter products than the code name alone suggests. State and local health authorities, cooperative purchasing alliances, and human services agencies use this code to procure generic multi-source pharmaceuticals, specialty pharmacy products, emergency medications, and OTC formulations for distribution across public health facilities, community health programs, and employee benefit plans. The issuing bodies include county health departments, state human services commissions, and multistate cooperative purchasing organizations that aggregate demand across dozens of participating jurisdictions and agencies.

Recent activity spans Florida, Minnesota, Oregon, and Texas. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in participating states including Oregon, with awards effective July 1, 2026 and a two-year term. Seminole County, Florida released an IFB (IFB60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The Texas Health and Human Services Commission posted a Request for Information in April 2026 to gather vendor capabilities regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling future formal competitive solicitations. Vendors pursuing this code should expect to provide detailed product information including NDC codes and manufacturing locations, maintain relationships with authorized wholesalers, certify compliance with cGMP and Drug Supply Chain Security Act requirements, carry substantial liability insurance, and accommodate cooperative purchasing frameworks that serve multiple state and local jurisdictions simultaneously.